Abstract
Objectives
To assess the effects of piroximone, a phosphodiesterase inhibitor, on right ventricular function in patients with heart failure.
Design
Randomized study: patients were randomly assigned to the piroximone infusion rate of 5 or 10 μg/kg/min.
Setting
Cardiologic intensive care unit.
Patients
12 consecutive patients with severe heart failure.
Interventions
Right heart catheterization was performed using a Swan-Ganz ejection fraction thermodilution catheter.
Measurements and results
Measurements of right ventricular ejection fraction (RVEF), end-diastolic and end-systolic right ventricular volumes were obtained using the thermodilution principle. To determine contractility indexes, the relationships between end-systolic pulmonary arterial pressure (ESPAP) over right ventricular end-systolic volume (RVESV) and ESPAP over RVEF were calculated during the infusion of prostacyclin at incremental infusion rates of 2, 4, 6 and 8 ng/kg/min. The slope of the relation between ESPAP over RVESV shifted during piroximone therapy from 7.635±1.632 to 1.975±0.432 (p<0.01) and from 6.092±1.99 to 1.028±0.853 (p<0.05) at 5 and 10 μg/kg/min piroximone infusion, respectively. The slope of the relation between ESPAP over RVEF decreased from −0.414±0.296 to −0.821±0.257 (p<0.01) and from −0.127±0.048 to −0.533±0.135 (p<0.05) at 5 and 10 μg/kg/min piroximone infusion, respectively.
Conclusions
This study suggests a positive action of piroximone on right ventricular contractility at these 2 dosages. This approach using this type of catheter allowed us to determine right ventricular inotropic indexes.
Similar content being viewed by others
References
Sibbald WJ, Driedger AA (1983) Right ventricular function in acute disease states: pathophysiologic considerations. Crit Care Med 11:339–345
Hurford WE, Zapol WM (1988) The right ventricle and critical illness: a review of anatomy, physiology, and clinical evaluation of its function. Intensive Care Med 14:448–457
Vincent JL, Thirion M, Brimioulle S, Lejeune P, Kahn RJ (1986) Thermodilution measurement of RVEF with a modified pulmonary artery catheter. Intensive Care Med 12:33–38
Dhainaut JF, Brunet F, Monsallier JF, Villemant D, Devaux JY, Konno M, De Gournay JM, Armaganidis A, Iotti G, Huyghebaert MJ, Lanore JJ (1987) Bedside evaluation of right ventricular performance using rapid computerized thermodilution method. Crit Care Med 15:148–152
Petein M, Levine B, Cohn JN (1984) Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure. J Am Coll Cardiol 4:364–371
Arbogast R, Brandt CM, Fincker JL, Schechter PJ (1986) Acute hemodynamic effects of piroximone in patients with moderate congestive heart failure: comparison with sodium nitroprusside. J Cardiovascular Pharm 8:82–89
Axelrod RJ, De Marco T, Dae M, Botvinick EH, Chatterjee K (1987) Hemodynamic and clinical evaluation of Piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure. J Am Coll Cardiol 9:1124–1130
Miller WE, Kennedy GT, Ruberg SJ, O'Rourke RA, Crawford MH (1988) Hemodynamic effects of a constant intravenous infusion of piroximone in patients with severe congestive heart failure. J Cardiovascular Pharm 12:72–77
Kerins DM, Murray R, FitzGerald GA (1991) Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility. Prog Hemost Thromb 10:307–337
Deleuze P, Dubois-Randé JL, Loisance D, Cachera JP (1992) Evaluation of enoximone vasodilating effects on animals implanted with a total artifical heart. J Thorac Cardiovasc Surg 103:589–594
Helier GV, Treves ST, Parker A (1986) Comparison of ultrashortlived Iridium 191m with technetium 99m for first pass radionuclide angiographic evaluation of right and left function in adults. J Am Coll Cardiol 7:1295–1302
Levine RA, Gibson TC, Aretz T, Gillan LD, Guyer DE, King ME, Weyman AE (1984) Echocardiographic measurement of right ventricular volume. Circulation 69:497–505
Kass DA, Mangham WL, Guo ZM, Kono A, Sunagawa K, Sagawa K (1987) Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationship. Circulation 6:1422–1436
Grossman W, Braunwald E, Mann T, Mc Laurin LP, Green LH (1977) Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relation. Circulation 56: 845–852
Dubois-Randé JL, Duval AM, Saal JP, Merlet P, Lellouche D, Deleuze Ph, Dupouy P, Brun Ph, Loisance D, Castaigne A (1991) Physiologic assessment of milrinone therapy in severe heart failure patients. J Cardiovasc Pharmacol 17:941–948
Yoshika Y, Nakajima H, Kawai C, Murakami T (1982) Prostacyclin therapy in patients with congestive heart failure. Am J Cardiol 50:320–324
DiBianco R (1991) Acute positive inotropic intervention: the phosphodiesterase inhibitors. Am Heart J 121:1871–1875
Hill NS, Rounds S (1983) Amrinone dilates pulmonary vessels and blunts hypoxic vasoconstriction in isolated rat lungs. Proc Soc Exp Biol Med 173205–213
Konstam MA, Cohen SR, Salem DN, Das D, Aronovitz MJ, Brockway BA (1986) Effect of amrinone on right ventricular function: predominance of afterload reduction. Circulation 74:359–366
Eichhorn EJ, Konstam MA, Weiland DS, Roberts DJ, Martin TT, Stransky NB, Salem DN (1987) Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 60:1329–1333
Maruschak GF, Schauble JF (1985) Limitations of thermodilution ejection fraction: Degradation of frequency response by catheter mounting of fast-response thermistors. Crit Care Med 13:679–682
Weber KT, Janicki JS, Shroff S, Fishman AP (1981) Contractile mechanisms and interaction of the right and left ventricle. Am J Cardiol 47:686–695
Weber KT, Janicki JS, Shroff SG, Likoff MJ, St John Sutton MG (1983) The right ventricle: Physiologic and pathophysiologic considerations. Crit Care Med 11:323–328
Brown KA, Ditchey RV (1988) Human right ventricular end-systolic pressure-volume relation defined by maximal elastance. Circulation 78:81–91
Konstam MA, Cohen SR, Salem DN, Conlon TP, Isner JM, Das D, Zile MR, Levine HJ, Kahn PC (1985) Comparison of left and right ventricular end-systolic pressure-volume relations in congestive heart failure. J Am Coll Cardiol 5:1326–1334
Mc Kay RG, Spears JR, Aroesty JM, Baim DS, Royal HD, Heller GV, Lincoln W, Salo RW, Braunwald E, Grossman W (1984) Instantaneous measurement of left and right ventricular stroke volume and pressure-volume relationships with an impedance catheter. Circulation 69:703–710
Borow KM, Come PC, Neuman A, Baim DS, Braunwald E, Grossman W (1985) Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease. Am J Cardiol 55:1204–1209
Kass DA, Mangham WL, Guo ZM, Kono A, Sunagawa K, Sagawa K (1987) Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationship. Circulation 6:1422–1436
Hines RL (1990) Management of acute right ventricular failure. J Cardiol Surg 5:285–287
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saal, J.P., Habbal, R., Estagnasie, P. et al. Effects of piroximone on the right ventricular function in severe heart failure patients. Intensive Care Med 20, 341–347 (1994). https://doi.org/10.1007/BF01720906
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01720906